3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
13
Stomach Neoplasms
12
Colorectal Neoplasms
8
Breast Neoplasms
8
Esophageal Neoplasms
7
Rectal Neoplasms
6
Lung Neoplasms
6
Carcinoma, Hepatocellular
6
Glioblastoma
5
Brain Neoplasms
5
Neoplasms
4
Neoplasm Metastasis
4
Colonic Neoplasms
4
Cholangiocarcinoma
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Ovarian Neoplasms
3
Lymphatic Metastasis
3
Glioma
3
Endometrial Neoplasms
3
Disease
3
Astrocytoma
3
Thyroid Neoplasms
2
Recurrence
2
Pain, Postoperative
2
Oropharyngeal Neoplasms
2
Melanoma
2
Laryngeal Neoplasms
2
Gliosarcoma
2
Gastrointestinal Stromal Tumors
2
Interventions
Cisplatin
4
tremelimumab
3
Pemetrexed
3
durvalumab
2
atezolizumab
2
Radiotherapy
2
Nivolumab
2
Mitomycin
2
Doxorubicin
2
toripalimab
1
talazoparib
1
rucaparib
1
regorafenib
1
ranpirnase
1
pembrolizumab
1
niraparib
1
liposomal doxorubicin
1
dostarlimab
1
cemiplimab
1
bemcentinib
1
avelumab
1
abemaciclib
1
Vinorelbine
1
Vinblastine
1
Thiostrepton
1
Surgical Procedures, Operative
1
Oxaliplatin
1
One-Lung Ventilation
1
Neoadjuvant Therapy
1
Megestrol Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Mesothelioma, Malignant
×
Surgical Procedures, Operative
×
Clear all
NCT06281860
2024-02-28
PITHAC
Centre Hospitalier Universitaire Vaudois
Phase 1
Unknown
39 enrolled